
With more than 15 years of experience in pharmaceutical business development and corporate strategy, Anand Patel is today poised to help further accelerate Capstone’s growth. He brings a wealth of knowledge in the generic and branded pharmaceutical space as a result of his diverse background in business segments such as investment banking, private equity and corporate strategy.
Before joining the Capstone leadership team, Anand headed business development and partnered on the portfolio strategy for branded, hospital, and generic divisions of Endo International. Previously, he held leading roles in business development and corporate strategy for several companies including Par Pharmaceuticals, JHP Pharmaceuticals, and EKR Therapeutics.